Unlock instant, AI-driven research and patent intelligence for your innovation.

Co-expression and purification method of conditionally activated binding proteins

An expression vector and protease cleavage technology, applied in the field of co-expression and purification of conditionally activated binding proteins, can solve the problems of reduced tumor accumulation, reduced specificity, and lack of affinity

Inactive Publication Date: 2021-04-16
MAVERICK THERAPEUTICS INC
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Single-chain fragments can be efficiently engineered from bacteria, however, due to the lack of avidity experienced by bivalent compounds, most engineered scFvs have a monovalent structure and Shows reduced tumor accumulation (e.g., shorter residence time on tumor cells) and reduced specificity
[0008] Despite the favorable properties of scFvs, certain features hinder their full-scale clinical deployment in cancer chemotherapy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Co-expression and purification method of conditionally activated binding proteins
  • Co-expression and purification method of conditionally activated binding proteins
  • Co-expression and purification method of conditionally activated binding proteins

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0290] A. Example 1: Method for generating half-COBRA pairs

[0291] Half-COBRA cannot act as a single molecule to induce T cell killing even after protease activation, however, two activated complementary half-COBRA molecules can induce potent T cell-mediated cytotoxicity against target-expressing cells (Figures 1 and 1). figure 2 ). This creates the problem of producing these molecules as drugs, since two protein molecules need to be produced. One solution is to form two expressing cell lines, each expressing a different half-COBRA, these two half-COBRAs can then be expressed and purified separately, and mixed to produce a prodrug mixture. Unfortunately, this is a time-consuming and expensive process to produce large doses of drug mixtures.

[0292] The solution to this problem is to co-express two half-COBRAs in the same cell and then purify them separately or together from the same conditioned medium.

[0293] image 3 Half-COBRA is shown to be co-expressed from transie...

Embodiment 2

[0320] B. Example 2: Generation of stable cell lines co-expressing half-COBRA pairs

[0321] This example illustrates an exemplary method for generating cell lines that co-express complementary half-COBRA pairs.

[0322] Materials and methods

[0323] All cell culture media, transfections were from Life Technologies. Transfection reagents include Expi293 Transfection Kit. The growth and expression medium used in the study was Expi293 expression medium. Selection medium included DMEM + 10% FBS + 0.5 mg / ml G418. All biosensors used for Octet analysis were from ForteBio, including SAX (high precision streptavidin) and His1K (Anti-Penta-His).

[0324] result

[0325] Figure 41 A schematic diagram of the two half-COBRA pairs used to generate co-expressing stable cell lines is shown in . Half-COBRA pairs are labeled differently to facilitate detection and purification. Each test pair included a first polypeptide with the following structure (N-terminal to C-terminal): s...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
affinityaaaaaaaaaa
volumeaaaaaaaaaa
Login to View More

Abstract

Provided herein are methods for co-expressing and purifying conditionally activated binding proteins such as hemi-COBRAs.

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS [0002] This application claims priority to US Provisional Application No. 62 / 716,755, filed August 9, 2018, the entire contents of which are expressly incorporated herein by reference in their entirety. [0003] References to "Sequence Listing", Tables or Computer Program Listing Appendices Submitted on CD-ROM [0004] The Sequence Listing, which is contained in a file named "118459-5006_ST25.txt" and is 183 kilobytes in size, has been submitted electronically via EFS-Web, and the contents of the txt file are hereby incorporated by reference in their entirety. Background technique [0005] In various clinical settings, it is often necessary to selectively destroy individual cells or specific cell types. For example, the main goal of cancer therapy is to specifically destroy tumor cells while leaving healthy cells and tissues as intact and undamaged as possible. One such approach is to allow immune effector cells such as natura...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61P35/00C07K16/18C07K16/28C07K16/30C12N15/85
CPCA61K2039/505A61P35/00C07K16/18C07K16/28C07K16/2809C07K16/2827C07K16/2863C07K16/30C07K2317/31C07K2317/569C07K2317/62C07K2317/622C07K2317/94C07K2319/00C07K2319/50C12N15/85C12N2800/108C12N2800/40
Inventor R·B·杜布里奇M·维诺格拉多沃娃Y·朱
Owner MAVERICK THERAPEUTICS INC